All the latest.

All articles

Pattern Secures $13M in Development Funding 

$6.8M CARB-X award plus $6.4M Series B led by Omnimed will help bring new technology to the fight against drug resistance. AUSTIN, Texas, February 4, 2020 – Pattern Bioscience, Inc., formerly operating as Klaris Diagnostics, today announced $13M in funding for the...

Klaris Named Finalist in AMR Diagnostic Challenge

Klaris has been selected as a finalist in the AMR Diagnostics Challenge federal prize competition, and will receive $100,000 to further develop its rapid ID/AST technology.  The Challenge is a joint effort between the National Institutes of Health and the HHS Office...